0.5 mg — studied in a trial
0.5 mg once a day for twenty days, under the tongue. (75 women, with a placebo group and an untreated group; the endpoints were a melatonin marker in urine and three clock genes in blood cells).
| Water added | Concentration | Draw |
|---|---|---|
| 1 mL | 10.00 mg/mL | 5.0 units |
| 2 mL | 5.00 mg/mL | 10.0 units |
| 3 mL | 3.33 mg/mL | 15.0 units |
limited human dataAraj SK, Brzezik J, Mądra-Gackowska K, Szeleszczuk Ł. Overview of Epitalon—Highly Bioactive Pineal Tetrapeptide with Promising Properties. Int J Mol Sci. 2025;26(6):2691 — an independent Medical University of Warsaw review whose Clinical Trials section reports both human studies of the tetrapeptide with their doses, enrollments and comparison groups · retrieved 2026-08-13
